C4 Therapeutics Operating Margin Growth & History (CCCC)

C4 Therapeutics's operating margin was −320.53% for fiscal 2025.

View full C4 Therapeutics company overview

C4 Therapeutics annual operating margin history

C4 Therapeutics annual operating margin

Fiscal yearPeriod endedOperating marginChange (percentage points)
20252025-12-31−320.53%+15.61 pp
20242024-12-31−336.15%+333.69 pp
20232023-12-31−669.84%−253.27 pp
20222022-12-31−416.56%−237.17 pp
20212021-12-31−179.39%

C4 Therapeutics operating margin trends

Across the available reported history, C4 Therapeutics's operating margin increased from −336.15% to −320.53%, a change of +15.61 percentage points. The latest reported quarter, Q2 2026, shows −397.88%.

About the metric

What operating margin means

Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.

Calculation and source

How operating margin is calculated

TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review C4 Therapeutics filings at SEC.gov ↗